Format

Send to

Choose Destination
See comment in PubMed Commons below
Childs Nerv Syst. 2009 Oct;25(10):1293-301. doi: 10.1007/s00381-009-0883-x. Epub 2009 Apr 10.

Salvage chemotherapy for metastatic and recurrent ependymoma of childhood.

Author information

1
Paediatric Neuro-Oncology Program, The Hospital for Sick Children, 555 University Avenue, Toronto, M5G1X8, Canada. eric.bouffet@sickkids.ca

Abstract

INTRODUCTION:

Chemotherapy has limited role in the up-front management of ependymoma. At the time of recurrence, the role of chemotherapy is also ill defined and the choice of chemotherapeutic agents is often arbitrary, based on anecdotal data and personal experience.

METHODS:

The purpose of this review is to describe and critically analyze the published literature on chemotherapy in patients with recurrent and metastatic ependymoma.

DISCUSSION:

The disappointing response rate with single agents (12.9%) and combinations (17.4%) emphasizes the need to re-evaluate the current chemotherapeutic approach of intracranial ependymoma, and biological studies are needed to identify targets that may be considered for clinical trials.

PMID:
19360417
DOI:
10.1007/s00381-009-0883-x
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center